Chemical activators of TSPYL3 employ various cellular pathways to modulate the protein's activity, primarily through the process of phosphorylation. Forskolin activates the enzyme adenylyl cyclase, which in turn elevates intracellular levels of cyclic AMP (cAMP). This surge in cAMP activates protein kinase A (PKA), a kinase that can directly phosphorylate TSPYL3, leading to its activation. Similarly, dibutyryl-cAMP, a cAMP analog, also stimulates PKA, achieving the same outcome. Phorbol 12-myristate 13-acetate (PMA) operates through a different pathway, activating protein kinase C (PKC), which can phosphorylate a broad range of substrates, including TSPYL3. Ionomycin raises intracellular calcium levels, which can activate calcium-dependent protein kinases capable of phosphorylating TSPYL3. In a parallel mechanism, thapsigargin disrupts calcium homeostasis by inhibiting the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), which also results in the activation of calcium-dependent kinases that can target TSPYL3.
Other chemical activators indirectly influence the phosphorylation status of TSPYL3. Okadaic Acid and Calyculin A inhibit protein phosphatases 1 and 2A, leading to sustained phosphorylation and consequent activation of TSPYL3 by preventing its dephosphorylation. Anisomycin, while primarily known as a protein synthesis inhibitor, activates stress-activated protein kinases (SAPKs) such as JNK and p38 MAP kinase, which may also phosphorylate and activate TSPYL3. Epigallocatechin gallate (EGCG) has a complex role, as it can inhibit certain protein kinases while activating others, potentially influencing the phosphorylation status of TSPYL3. Sphingosine can be converted to sphingosine-1-phosphate (S1P), which engages S1P receptors and activates downstream protein kinases that may phosphorylate TSPYL3. Lastly, H-89 and Bisindolylmaleimide I, although primarily inhibitors of PKA and PKC respectively, can activate other kinases through off-target effects, possibly resulting in the phosphorylation and activation of TSPYL3. Each of these chemicals, through their unique interactions with cellular signaling pathways, converges on the regulation of TSPYL3 activity via phosphorylation events.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP can enhance the phosphorylation of proteins, which may include TSPYL3, by protein kinase A (PKA). This phosphorylation can lead to functional activation of TSPYL3. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC) which is known to phosphorylate a wide range of target proteins. PKC-mediated phosphorylation can lead to the activation of TSPYL3, as part of downstream signaling cascades. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin acts as a calcium ionophore, raising intracellular calcium levels. This increase can activate calcium-dependent protein kinases which may in turn activate TSPYL3 through phosphorylation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatases 1 and 2A, which prevents dephosphorylation of proteins. By inhibiting dephosphorylation, okadaic acid can result in the sustained activation of proteins like TSPYL3 that are regulated through phosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that also activates stress-activated protein kinases such as JNK and p38 MAP kinase. The activation of these kinases can lead to the phosphorylation and activation of target proteins, potentially including TSPYL3. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Calyculin A, like okadaic acid, is an inhibitor of protein phosphatases, particularly PP1 and PP2A. Its inhibition of these phosphatases can lead to increased phosphorylation and consequent activation of TSPYL3. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG has been found to inhibit certain types of protein kinases, while it can activate others indirectly. Such kinase activation may lead to the phosphorylation and activation of proteins like TSPYL3. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. Activation of PKA leads to phosphorylation of proteins, which can include TSPYL3, leading to its activation. | ||||||
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $88.00 $190.00 $500.00 $2400.00 $9200.00 $15000.00 | 2 | |
Sphingosine can be phosphorylated to form sphingosine-1-phosphate (S1P), which activates S1P receptors and can lead to downstream activation of protein kinases that phosphorylate and activate proteins like TSPYL3. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin inhibits the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to a rise in cytosolic calcium levels, which can activate calcium-dependent kinases that might phosphorylate and activate TSPYL3. |